Bleeding and Platelet Disorders
Gene: MED12
- There's no clear geno-pheno correlation. Missense can cause any of the phenos (FGS1, LS, Ohdo and nonsyndromic ID; Charzewska 2018).
- de novo PTCs cause female-specific Hardikar syndrome, very skewed X inactivation (Li, 2020)
- Several affected female carriers have been reported: usually with milder clinical manifestation, several families showed skewed X-chr inactivation pattern in affected female carriers (Wang 2020). However some families had no correlation between clinical outcome and X-chr inactivation in the blood samples (Charzewska 2018, Prontera 2016).Created: 23 Mar 2021, 4:42 a.m. | Last Modified: 23 Mar 2021, 4:42 a.m.
Panel Version: 0.6863
Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Phenotypes
Ohdo syndrome, X-linked MIM#300895; Lujan-Fryns syndrome MIM#309520; Opitz-Kaveggia syndrome MIM#305450
Publications
Included here due to association with aortic aneurysm.Created: 15 Aug 2020, 6:36 a.m. | Last Modified: 15 Aug 2020, 6:36 a.m.
Panel Version: 0.110
Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females
Phenotypes
Lujan-Fryns syndrome, MIM# 309520
Gene: med12 has been classified as Green List (High Evidence).
Phenotypes for gene: MED12 were changed from to Lujan-Fryns syndrome, MIM# 309520
Mode of inheritance for gene: MED12 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females
gene: MED12 was added gene: MED12 was added to Bleeding Disorders_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: MED12 was set to Unknown